“������������KA���:ZA31���24������ ���������������������������������”的搜索结果，显示 1-10 项，共有 3373 项

1. Untitled

   Page 1.

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 24 weeks of vincristine and dactinomycin (VA) and examines the use of centralized molecular risk stratification in the treatment of rhabdomyosarcoma.

3. 外科 - 临床试验- 妙佑医疗国际

   ... 24; Month 6) Visit 9 (Week 52; Month 12). Visit 10 (Week 104, Month 24). Mayo Clinic Upper Digestive Disease Survey. Rochester, Minn. The Mayo Clinic Upper ...

4. 外科 - 临床试验- 妙佑医疗国际

   ... 24; Month 6) Visit 9 (Week 52; Month 12). Visit 10 (Week 104, Month 24). Outcome of Capsular Release for Elbow Contracture. Rochester, Minn. The purpose of ...

5. 放射肿瘤科- 临床试验- 妙佑医疗国际

   24 研究放射肿瘤科（仅限仍在招募的研究）. 按院区、状态和其他条件筛选该研究列表。 Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating ...

6. 临床试验- 妙佑医疗国际儿童中心

   Rochester, Minn. You are being asked to take part in this research registry because you or your family member is suspected to have a 24-hydroxylase deficiency.

7. 临床试验 - 妙佑医疗国际儿童中心 - 妙佑医疗国际儿童中心

   Rochester, Minn. You are being asked to take part in this research registry because you or your family member is suspected to have a 24-hydroxylase deficiency.

8. 临床试验 - 妙佑医疗国际儿童中心 - 妙佑医疗国际儿童中心

   Rochester, Minn. You are being asked to take part in this research registry because you or your family member is suspected to have a 24-hydroxylase deficiency.

9. Ratio of 25OHD-to-2425OH2D A new test to confirm 24-hydroxylase CYP24A1 deficiency as the cause of hypercalcemia - 妙佑医疗国际

   Ratio of 25OHD-to-2425OH2D A new test to confirm 24-hydroxylase CYP24A1 deficiency as the cause of hypercalcemia. MAC-20430939.

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The objective of this study is to collect tumor specimens (tumor tissues, matched normal tissue when possible, and 50 mL of blood) that may inform cancer ...